1. Modular medical imaging agents based on azide-alkyne Huisgen cycloadditions: Synthesis and pre-clinical evaluation of 18F-labeled PSMA-tracers for prostate cancer imaging

   Böhmer, V. I., Szymanski, W., van den Berg, K-O., Mulder, C., Kobauri, P., Helbert, H., van den Born, D., Reeβing, F., Huizing, A., Klopstra, M., Samplonius, D. F., Antunes, I. F., Sijbesma, J. W. A., Luurtsema, G., Helfrich, W., Visser, T. J., Feringa, B. L. & Elsinga, P. H., 21-Apr-2020, In : Chemistry. 24 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery

   Reeßing, F., Stuart, M. C. A., Samplonius, D. F., Dierckx, R. A. J. O., Feringa, B. L., Helfrich, W. & Szymanski, W., 16-Sep-2019, In : Chemical communications (Cambridge, England). 55, 72, p. 10784-10787 4 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint Blockade

   Koopmans, I., Hendriks, M. A. J. M., van Ginkel, R. J., Samplonius, D. F., Bremer, E. & Helfrich, W., Nov-2019, In : Journal of Investigative Dermatology. 139, 11, p. 2343-+ 12 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Targeting the messengers of death: the advent of selective activation of apoptosis for cancer therapy.

   Bremer, E. & Helfrich, W., 1-Jan-2006, In : Discovery medicine. 6, 33, p. 113-117 5 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Development of Bispecific Antibody Derivatives for Cancer Immunotherapy

   He, Y., Helfrich, W. & Bremer, E., 2019, Cancer Immunosurveillance: Methods and Protocols. Humana Press, p. 335-347 13 p. (Methods in Molecular Biology).

   Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

View all (106) »